Shinwa is eyeing sales of three systems in the first year and 30 over three years. The Minnetonka, Minnesota company's system allows microprocessor, chipset, motherboard and PC manufacturers to test and verify the compatibility of their products with existing PC software, including operating systems, application programs and games. This surgical process is designed for patients with chronic, severe coronary artery disease who have no other treatment alternatives. It will apply shortly to the Ministry of Health and Welfare for marketing approval. The test is based on the Newton, Massachusetts company's proprietary nuclear matrix protein technology, which correlates levels of NMPs in body fluids to the presence of cancer.
Customers can order up to a three-month supply at one time.
Disposable lenses now represent about 30 percent of Japan's contact lens market.